Effect of lovastatin on hemorheology in type II hyperlipoproteinemia
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 83 (1), 53-58
- https://doi.org/10.1016/0021-9150(90)90130-b
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.Circulation, 1987
- INCREASED BLOOD VISCOSITY AND FIBRINOLYTIC INHIBITOR IN TYPE II HYPERLIPOPROTEINAEMIAThe Lancet, 1982
- Effects of lipoproteins on plasma viscosityAtherosclerosis, 1981
- Influence of clofibrate on blood viscosity in primary hyperlipoproteinemiaKlinische Wochenschrift, 1979
- Studies of plasma viscosity in primary hyperlipoproteinaemiaAtherosclerosis, 1977
- Influence of etofibrate on plasma fibrinogen and plasminogen concentrations in patients with different forms of primary hyperlipoproteinemiaAtherosclerosis, 1976
- Effect of Clofibrate on Blood Viscosity in Intermittent ClaudicationBMJ, 1974
- Further observations on the effect of ethyl-α-p-chlorophenoxyisobutyrate + androsterone (Atromid) on plasma fibrinogen and serum cholesterol in patients with ischaemic heart diseaseJournal of Atherosclerosis Research, 1966
- A NEW INSTRUMENT FOR THE MEASUREMENT OF PLASMA-VISCOSITYThe Lancet, 1963
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957